Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Clinical trials in Asia: A World Health Organization database study.

Ali S, Egunsola O, Babar ZUD, Hasan SS.

Perspect Clin Res. 2019 Jul-Sep;10(3):121-124. doi: 10.4103/picr.PICR_109_18.

2.

Pharmacy, pharmaceuticals and public policy: Solving the puzzle.

Nagaria RA, Hasan SS, Babar ZU.

Res Social Adm Pharm. 2019 Jul 18. pii: S1551-7411(19)30400-0. doi: 10.1016/j.sapharm.2019.07.010. [Epub ahead of print]

PMID:
31351779
3.

Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000-2018.

Ramzan S, Timmins P, Hasan SS, Babar ZU.

Prim Care Diabetes. 2019 Jun 15. pii: S1751-9918(19)30130-5. doi: 10.1016/j.pcd.2019.05.009. [Epub ahead of print] Review.

PMID:
31213359
4.

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.

Kasonde L, Tordrup D, Naheed A, Zeng W, Ahmed S, Babar ZU.

BMC Health Serv Res. 2019 Jun 13;19(1):383. doi: 10.1186/s12913-019-4221-z.

5.

Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel.

Husnain SZ, Bukhari NI, Hussain K, Babar ZU, Hashmi FK, Saleem Z, Salman M, Curley L.

BMC Health Serv Res. 2019 May 22;19(1):328. doi: 10.1186/s12913-019-4145-7.

6.

A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants.

Afzal SK, Hasan SS, Babar ZU.

Br J Clin Pharmacol. 2019 May 11. doi: 10.1111/bcp.13985. [Epub ahead of print] Review.

PMID:
31077431
7.

Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review.

Bain A, Hasan SS, Babar ZU.

Diabet Med. 2019 Aug;36(8):948-960. doi: 10.1111/dme.13982. Epub 2019 Jun 10. Review.

PMID:
31050037
8.

Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.

Saeed A, Saeed H, Saleem Z, Fang Y, Babar ZU.

PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019.

9.

The Fourth Industrial Revolution: Will it change pharmacy practice?

Baines D, Nørgaard LS, Babar ZU, Rossing C.

Res Social Adm Pharm. 2019 Apr 16. pii: S1551-7411(19)30355-9. doi: 10.1016/j.sapharm.2019.04.003. [Epub ahead of print]

PMID:
31010746
10.

What drives inappropriate use of antibiotics? A mixed methods study from Bahawalpur, Pakistan.

Atif M, Asghar S, Mushtaq I, Malik I, Amin A, Babar ZU, Scahill S.

Infect Drug Resist. 2019 Mar 26;12:687-699. doi: 10.2147/IDR.S189114. eCollection 2019.

11.

Extensively drug-resistant typhoid fever in Pakistan.

Rasheed MK, Hasan SS, Babar ZU, Ahmed SI.

Lancet Infect Dis. 2019 Mar;19(3):242-243. doi: 10.1016/S1473-3099(19)30051-9. No abstract available.

PMID:
30833059
12.

Editorial: Medicines pricing, access and safety in Morocco.

Tuck C, Maamri A, Chan AHY, Babar ZU.

Trop Med Int Health. 2019 Mar;24(3):260-263. doi: 10.1111/tmi.13191. Epub 2019 Jan 11.

13.

Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.

Hasan SS, Kow CS, Dawoud D, Mohamed O, Baines D, Babar ZU.

Value Health Reg Issues. 2019 May;18:18-23. doi: 10.1016/j.vhri.2018.08.007. Epub 2018 Nov 7.

PMID:
30414506
14.

A comparison of warfarin monitoring service models.

Hasan SS, Sunter W, Ahmed N, Royle-Pryor A, Brkic A, Ahmed R, Afzal S, Babar ZU.

Res Social Adm Pharm. 2018 Oct 30. pii: S1551-7411(18)30768-X. doi: 10.1016/j.sapharm.2018.10.029. [Epub ahead of print]

PMID:
30396826
15.

Association between the Vicious Cycle of Diabetes-Associated Complications and Glycemic Control among the Elderly: A Systematic Review.

Atif M, Saleem Q, Babar ZU, Scahill S.

Medicina (Kaunas). 2018 Oct 15;54(5). pii: E73. doi: 10.3390/medicina54050073. Review.

16.

Cost analysis of type 2 diabetes mellitus treatment in economically developed countries.

Ramzan S, Timmins P, Hasan SS, Babar ZU.

Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):5-14. doi: 10.1080/14737167.2018.1513790. Epub 2018 Sep 4. Review.

PMID:
30146917
17.

A Scoping Review of the Quality and the Design of Evaluations of Mobile Health, Telehealth, Smart Pump and Monitoring Technologies Performed in a Pharmacy-Related Setting.

Baines D, Gahir IK, Hussain A, Khan AJ, Schneider P, Hasan SS, Babar ZU.

Front Pharmacol. 2018 Jul 26;9:678. doi: 10.3389/fphar.2018.00678. eCollection 2018. Review.

18.

Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries.

Eljilany I, El-Dahiyat F, Curley LE, Babar ZU.

Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):403-414. doi: 10.1080/14737167.2018.1479254. Epub 2018 May 30. Review.

PMID:
29779401
19.

Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults.

Hasan SS, Kow CS, Curley LE, Baines DL, Babar ZU.

Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):371-377. doi: 10.1080/14737167.2018.1474101. Epub 2018 May 9. Review.

PMID:
29741099
20.

Consolidated Medication Review Algorithm to Improve Medications Use in Older Adults: Components, Scoring Scheme, and Implementation.

Thiruchelvam K, Wong PS, Kairuz T, Babar ZU, Hasan SS.

J Am Med Dir Assoc. 2018 Aug;19(8):717-718. doi: 10.1016/j.jamda.2018.03.007. Epub 2018 Apr 19. No abstract available.

PMID:
29680204

Supplemental Content

Loading ...
Support Center